Zentek Announces Non-Brokered Private Placement of Units for up to $3 Million
Zentek Announces Non-Brokered Private Placement of Units for up to $3 Million
Guelph, ON – July 23, 2024, Zentek Ltd. ("Zentek" or the "Company") (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property development and commercialization company is pleased to announce its intention to complete a non-brokered private placement of up to $3 million through the issuance of up to 2,307,692 units (the "Units") in the capital of the Company at a price of $1.30 per Unit (the "Offering"). Gross proceeds of the Offering will be used for working capital and general corporate purposes.
安大略省盖尔夫——2024年7月23日,知识产权开发和商业化公司Zentek Ltd.(“Zentek” 或 “公司”)(纳斯达克股票代码:ZEN)欣然宣布,打算通过在公司资本中发行最多2,307,692单位(“单位”),完成高达300万美元的非经纪私募配售,价格为每单位 1.30 美元(“产品”)。本次发行的总收益将用于营运资金和一般公司用途。
Each Unit consists of one common share (each, a "Common Share") and one-half of one Common Share purchase warrant (each, a "Warrant"). Each whole Warrant entitles the holder thereof to purchase one Common Share at a price of $3.00 for a period of 24 months from the closing date of the Offering.
每个单位由一股普通股(每股均为 “普通股”)和一半的普通股购买权证(均为 “认股权证”)组成。每份完整认股权证的持有人有权在自发行截止之日起24个月内以3.00美元的价格购买一股普通股。
Closing of the Offering is subject to receipt of all necessary corporate and regulatory approvals, including the approval of TSX Venture Exchange. All securities issued in connection with the Offering will be subject to a hold period of four months plus a day from the date of issuance and the resale rules of applicable securities legislation.
本次发行的结束需获得所有必要的公司和监管部门的批准,包括多伦多证券交易所风险投资交易所的批准。与本次发行有关的所有证券的持有期将为四个月加一天,持有期自发行之日起一天,并受适用证券立法的转售规则约束。
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
本新闻稿不构成在美国出售任何证券的要约或招揽出售任何证券的要约。这些证券过去和将来都不会根据经修订的1933年《美国证券法》(“美国证券法”)或任何州证券法进行注册,除非根据美国《证券法》和适用的州证券法进行注册或获得此类注册豁免,否则不得在美国境内或向美国个人发行或出售。
About Zentek Ltd.
关于 Zentek Ltd
Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener.
Zentek是一家通过ISO 13485:2016 认证的知识产权技术公司,专注于新产品的研究、开发和商业化,旨在通过使公司的商业合作伙伴的产品更好、更安全、更环保,从而为其商业合作伙伴提供竞争优势。
Zentek's patented technology platform ZenGUARD, is shown to have 99-per-cent anti-microbial activity and to significantly increase the viral filtration efficiency for surgical masks and aims to do the same for HVAC (heating, ventilation, and air conditioning) systems. Zentek's ZenGUARD production facility is located in Guelph, Ontario.
Zentek的专利技术平台ZenGuard被证明具有99%的抗微生物活性,可显著提高外科口罩的病毒过滤效率,其目标是对HVAC(供暖、通风和空调)系统起到同样的作用。Zentek 的 ZenGuard 生产设施位于安大略省圭尔夫。
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
不适用于分发给美国新闻通讯社或在美国传播
For further information on Zentek:
有关 Zentek 的更多信息:
investorrelations@zentek.com
investorrelations@zentek.com
Ryan Shacklock
Senior VP, Strategy & Business Development
Email: rshacklock@zentek.com
Phone: 306-270-9610
Ryan Shacklock
战略与业务发展高级副总裁
电子邮件:rshacklock@zentek.com
电话:306-270-9610
To find out more about Zentek, please visit our website at . A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at .
要了解有关 Zentek 的更多信息,请访问我们的网站。本新闻稿和与公司有关的所有重要文件的副本可在Zentek的SEDAR+个人资料上获得,网址为。
Forward-Looking Statements
前瞻性陈述
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
本新闻稿包含前瞻性陈述。由于前瞻性陈述涉及未来的事件和状况,因此就其本质而言,它们涉及固有的风险和不确定性。尽管Zentek认为在本新闻稿中准备前瞻性信息时使用的假设和因素是合理的,但不应过分依赖此类信息,此类信息仅在本新闻稿发布之日适用,也无法保证此类事件会在披露的时间范围内发生或根本不会发生。除非法律要求,否则Zentek不打算或有义务更新或修改任何前瞻性信息,无论是由于新信息、未来事件还是其他原因。
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
多伦多证券交易所风险投资交易所及其监管服务提供商(该术语在多伦多证券交易所风险投资交易所的政策中定义)均不对本新闻稿的充分性或准确性承担责任。